Inflammatory Bowel Diseases - ECAB

Author: Augustine> Philip  

Publisher: Elsevier Health Sciences APAC‎

Publication year: 2012

E-ISBN: 9788131231913

P-ISBN(Paperback): 9788131215586

Subject: R516.1 enteritis

Keyword: 内科学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Inflammatory bowel disease (IBD) encompasses a spectrum of autoimmmune diseases which include ulcerative colitis, Crohn's disease, and indeterminate colitis. Ulcerative colitis is a relapsing nontransmural inflammatory disease restricted to colon, which may be classified as proctitis, left-sided colitis, or pancolitis depending on the extent of involvement. Some patients also develop ileal inflammation (backwash ileitis), which occasionally complicates its differentiation from Crohn's ileocolitis. Crohn's disease is defined as a relapsing transmural inflammatory disease of gastrointestinal mucosa that may affect the entire gastrointestinal tract (GIT) from the mouth to the anus. There is discontinuous involvement of various portions of the GIT and may get complicated by formation of strictures, abscesses, or fistulas. It closely resembles intestinal tuberculosis both clinically and on investigations. GI tuberculosis is often suspected on the basis of its clinical, radiological, and endoscopic features, but histological or microbiologic proof of the disease is often difficult to achieve. Therefore, the majority of patients are treated with antitubercular drugs on presumptive diagnosis only. Similar clinical, endoscopic, radiological, and histological features of GI tuberculosis and Crohn's disease pose a serious challenge to the treating physician. The rate of misdiagnosis of these conditions using conventional diagnostic measures has been reported to be around 50-70%. Thus d

Chapter

Foreword

Diagnosis of Inflammatory Bowel Disease

ABSTRACT

KEYWORDS

Epidemiology

Indian Update

Etiology

Pathogenesis

Molecular Classification of IBD

IBD and Colorectal Cancer Risk

Diagnostic Procedures

Routine Laboratory Screening

Gastrointestinal Endoscopy

Videocapsule Endoscopy

Double Balloon Enteroscopy

Histopathology

Serological Biomarkers

Radiological Procedures

Barium Studies

Ultrasound

Computed Tomography

Magnetic Resonance Imaging

MRI studies: Current status

Advantages and limitations of MRI

Scintigraphy

Diagnostic Algorithms

Recent Advances

Predicting a Change in Diagnosis from UC to CD

Is Endoscopic Ultrasound Appropriate for the Diagnosis?

Conclusion

Case Studies Diagnosis of Inflammatory Bowel Disease

Case Study I

History

On Examination

Management

Discussion

Case Study II

History

On Examination

Discussion

Case Study III

History

On Examination

Management

Case Study IV

History

On Examination

Management

Discussion

Differentiation of Crohns Disease from Intestinal Tuberculosis

ABSTRACT

KEYWORDS

Changing Epidemiology of the Inflammatory Bowel Disease

Pathogenesis

Genetic Factors

Environmental Factors

Role of Immunosuppressants

Clinical Features

Diagnosis

Diagnostic Tools

Tuberculin Skin Testing

Use of Radiology

Role of Endoscopy

Colonoscopic Biopsy

Role of Laparoscopy in Diagnosis

Serological Markers

Anti-Saccharomyces Cerevisiae Antibody

PCR Assay

Histological Criteria

Mycobacterial Culture

Diagnostic Approach For Suspected Gitb/Cd In India

Treatment

Complications

Conclusion

Emerging Therapies in Inflammatory Bowel Disease

ABSTRACT

KEYWORDS

Drugs Used in IBD

Corticosteroids

Aminosalicylates

Ulcerative Colitis

Maintenance of remission

Crohn's Disease

Role in induction of remission

Role in maintenance of remission

Thiopurines

Methotrexate

Crohn's Disease

Ciclosporin

Ulcerative Colitis

Crohn's Disease

Biological Therapy

Anti-TNF Therapies

Infliximab

Infliximab in CD

Recommendations and caution

Adverse effects of infliximab

Adalimumab

Certolizumab Pegol (CDP870)

Natalizumab

Fish Oil

Probiotics

Cytapheresis

Medical Management of Inflammatory Bowel Disease

Medical Management of UC

Induction of Remission for Active Left-sided UC

Treatment of Severe UC

Maintenance Therapy in UC

Medical Management of CD

Mildly Active Localized Ileocecal CD

Moderately Active Localized Ileocecal CD

Severel Localized Ileocecal CD

Colonic Disease

Extensive Small Bowel Disease

Early Relapse

Corticosteroid-dependent CD

Corticosteroid Refractory CD

Maintenance of Remission in CD

Management of Fistulising CD

Simple Perianal Fistulas

Complex Perianal Disease

Management of Nonperianal Fistulating CD

CD and Pregnancy

Summary

Case Studies Emerging Therapies in Inflammatory Bowel Disease

Case Study I

History

Examination and Management

Discussion

Case Study II

History

Examination and Management

Discussion

Genetics of Inflammatory Bowel Disease

ABSTRACT

KEYWORDS

Crohn's Disease

IBD 1

IBD 4

IBD 5

IBD 6

IBD 7

IBD 8

IBD 9

Other Loci

Chromosome 2

Chromosome 4

Chromosome 10

Chromosome 11

Chromosome 13

Genes Involved in Innate Immune Response

Genes Involved in Disease Modification Rather than Prevalence

Ulcerative Colitis

IBD 2

IBD 3

Communicable Ulcerative Colitis

Genes Involved in Disease Modification Rather than Prevalence

Summary

Other Books in This Series

The users who browse this book also browse